Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet function in type 2 diabetes patients with and without renal impairment under lipid-lowering treatment
2004-004416-22Phase 4Completed
- Sponsor
- Karolinska Institutet
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of simvastatin and ezetimibe in type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD) (3 arms), sponsored by Karolinska Institutet. Primary endpoint: ADP-stimulated platelet P-selectin expression. Started Dec 2004; status: completed.
02
Drugs
simvastatinezetimibe
03
Conditions
type 2 diabetes mellitus (T2DM)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2004-004416-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004416-22.